Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

被引：2
|
作者：
Vici, Patrizia [1 ]
Pizzuti, Laura [1 ]
Krasniqi, Eriseld [1 ]
Botticelli, Andrea [2 ]
Ciliberto, Gennaro [3 ]
Barba, Maddalena [1 ]
机构：
[1] IRCCS Regina Elena Natl Canc Inst, Div Med Oncol 2, Rome, Italy
[2] Univ Rome Sapienza, Dept Clin & Mol Oncol, Rome, Italy
[3] IRCCS Regina Elena Natl Canc Inst, Sci Direct, Rome, Italy
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 10期
关键词：
Covid-19; immunotherapy; metastatic triple-negative breast cancer; COVID-19; IMMUNOTHERAPY; TOXICITIES; SURVIVAL; RECEPTOR; PD-L2;
D O I：
10.2217/imt-2020-0142
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：675 / 679
页数：5
相关论文
共 50 条
  • [1] Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
    Nishio, Minako
    Kojitani, Yoshiki
    Kitashiro, Saya
    Ishiduka, Yasunobu
    Otsuka, Tomoyuki
    Nishida, Naohiro
    Fujisawa, Fumie
    Sugimoto, Naotoshi
    Yagi, Toshinari
    Souma, Ai
    Kanaoka, Haruka
    Oyamayama, Yuri
    Taniguchi, Azusa
    Nakajima, Satomi
    Seto, Yukiko
    Kusama, Hiroki
    Watanabe, Noriyuki
    Matsui, Saki
    Nakayama, Takahiro
    Kudou, Toshihiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1465 - S1465
  • [2] Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
    Valenza, Carmine
    Trapani, Dario
    Zagami, Paola
    Antonarelli, Gabriele
    Bielo, Luca Boscolo
    Nicolo, Eleonora
    Ribeiro, Joana Mourato
    Guidi, Lorenzo
    Reduzzi, Carolina
    Spotti, Martina
    Adamoli, Laura
    Cortes, Javier
    Pistilli, Barbara
    Tolaney, Sara M.
    Ueno, Naoto
    Layman, Rachel M.
    Cristofanilli, Massimo
    Carey, Lisa A.
    Munzone, Elisabetta
    Criscitiello, Carmen
    Lynce, Filipa
    Woodward, Wendy A.
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2024, 213
  • [3] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [4] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Laura L. Michel
    Alexandra von Au
    Athanasios Mavratzas
    Katharina Smetanay
    Florian Schütz
    Andreas Schneeweiss
    Targeted Oncology, 2020, 15 : 415 - 428
  • [5] Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
    Simmons, Christine E.
    Brezden-Masley, Christine
    McCarthy, Joy
    McLeod, Deanna
    Joy, Anil Abraham
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [6] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Steiner, Meghan
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
  • [7] Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer
    Quintana, A.
    Saini, K. S.
    Vidal, L.
    Peg, V.
    Slebe, F.
    Loibl, S.
    Curigliano, G.
    Schmid, P.
    Cortes, J.
    ESMO OPEN, 2024, 9 (10)
  • [8] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Singh, Sima
    Numan, Arshid
    Maddiboyina, Balaji
    Arora, Saahil
    Riadi, Yassine
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
  • [9] SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors
    Yang Yang
    Gaosi Xu
    Cell Death & Disease, 14
  • [10] SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors
    Yang, Yang
    Xu, Gaosi
    CELL DEATH & DISEASE, 2023, 14 (06)
12345